Oncology Central

Hair loss gene could be exploited to improve cancer immunotherapy

A novel mouse study has demonstrated that the gene IKZF1, which is associated with the hair loss condition alopecia areata, could be exploited to improve cancer immunotherapy. The findings were recently published in Cell Systems.
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.